ZYOMYX

About:

Zyomyx develops and commercializes diagnostic platforms, including a point-of-care test for HIV/AIDS.

Website: http://www.zyomyx.com

Top Investors: Bill & Melinda Gates Foundation, Jenny Rooke

Description:

Zyomyx has a unique expertise in and passion for tackling difficult “outside-the-box” problems. Highly user-friendly, instrument-free point-of-care tests need to be designed with an advanced level of cartridge engineering and reagent stability, and aligned with aggressive cost targets. Zyomyx specializes in exactly these demanding product requirements. Our immediate focus is an advanced, but simple to use and inexpensive CD4 T-cell point-of-care test that will be launched globally and configured to especially meet the demanding specifications for use in low and middle income countries.

Total Funding Amount:

$34.3M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Fremont, Missouri, United States

Founded Date:

1998-01-01

Contact Email:

info(AT)zyomyx.com

Founders:

Peter Wagner

Number of Employees:

51-100

Last Funding Date:

2014-03-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai